PATIENT REPORTED OUTCOMES AMONG PATIENTS RECEIVING TREATMENT FROM THE PEGLOTICASE PHASE 3 CLINICAL TRIALS FOR UNCONTROLLED GOUT

被引：1
|
作者：
Sparks, J. [1 ]
Obermeyer, K. [2 ]
Lamoreaux, B. [3 ]
机构：
[1] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA
[2] Horizon Therapeut Plc, Biostat, Deerfield, IL USA
[3] Horizon Therapeut Plc, Med Affairs, Deerfield, IL USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
QUALITY-OF-LIFE;
D O I：
10.1136/annrheumdis-2022-eular.1156
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1039
引用
收藏
页码：1643 / 1643
页数：1
相关论文
共 50 条
  • [21] The value of patient-reported outcomes in early-phase clinical trials
    Retzer, Ameeta
    Aiyegbusi, Olalekan Lee
    Rowe, Anna
    Newsome, Philip N.
    Douglas-Pugh, Jessica
    Khan, Sheeba
    Mittal, Saloni
    Wilson, Roger
    O'Connor, Daniel
    Campbell, Lisa
    Mitchell, Sandra A.
    Calvert, Melanie
    NATURE MEDICINE, 2022, 28 (01) : 18 - 20
  • [22] REVIEW OF PATIENT-REPORTED OUTCOMES IN PHASE II ONCOLOGY CLINICAL TRIALS
    Danheiser, S.
    Barkalow, F.
    Finnern, H. W.
    VALUE IN HEALTH, 2010, 13 (07) : A275 - A275
  • [23] Clinical and patient-reported outcomes in clinical trials of abatacept in the treatment of rheumatoid arthritis
    Massarotti, Elena M.
    CLINICAL THERAPEUTICS, 2008, 30 (03) : 429 - 442
  • [24] Using Patient-Reported Outcomes to Describe the Patient Experience on Phase I Clinical Trials
    Sedhom, Ramy
    Ferrell, Betty
    Ruel, Nora
    Koczywas, Marianna
    Chung, Vincent
    Smith, Thomas J.
    JNCI CANCER SPECTRUM, 2020, 4 (06)
  • [25] Patient satisfaction, outcomes and experience measures among patients receiving propofol: A patient reported outcomes measure study
    Garlapati, Arushi
    Harsha, Chalasani Sri
    Pradhan, Jalapa
    Murthy, Spoorthy S.
    Rozampuii, C.
    Mohan, C. H.
    Madhan, Ramesh
    Gurudath, C. L.
    Syed, Jehath M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 571 - 571
  • [26] PEGLOTICASE/METHOTREXATE CO-THERAPY IMPROVED JOINT AND PATIENT-REPORTED HEALTH ASSESSMENTS IN PATIENTS WITH UNCONTROLLED GOUT: 12-MONTH EXPLORATORY OUTCOMES OF THE MIRROR OPEN-LABEL TRIAL
    Botson, J.
    Peloso, P. M.
    Obermeyer, K.
    Lamoreaux, B.
    Zhao, L.
    Weinblatt, M. E.
    Peterson, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1348 - 1349
  • [27] Patient-Reported Outcomes Among Sham vs No-Treatment Controls From Randomized Trials
    Hawkins, Barbara S.
    Bressler, Neil M.
    Reynolds, Sandra M.
    ARCHIVES OF OPHTHALMOLOGY, 2011, 129 (02) : 200 - 205
  • [28] CLINICAL OUTCOMES OF PATIENTS WITH HEMOPHILIA RECEIVING DIFFERENT TREATMENT REGIMENS IN CHINA: BASED ON PATIENT-REPORTED DATA
    Zhang, L.
    Zhang, P.
    Chen, W.
    VALUE IN HEALTH, 2022, 25 (07) : S325 - S325
  • [29] Measuring patient-reported outcomes: moving from clinical trials into clinical practice
    Valderas, Jose M.
    Alonso, Jordi
    Guyatt, Gordon H.
    MEDICAL JOURNAL OF AUSTRALIA, 2008, 189 (02) : 93 - 94
  • [30] Patient-Reported Outcomes for Tolerability Assessment in Phase I Cancer Clinical Trials
    Basch, Ethan
    Yap, Christina
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (08): : 943 - 944
12345